While several Democrats expressed outrage over the possibility that President Donald Trump’s temporary federal spending ...

With a sweep of the pen, President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

There’s no better model of efficiency — the very platform of the Trump administration — than telehealth, which has proven to ...

Thursday marks another day of Senate confirmation hearings for Robert F. Kennedy Jr., Kash Patel and Tulsi Gabbard.

A bill has been introduced in the US House of Representatives aimed at overturning a rule implemented during the Biden ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

Karnik, federal policy director of the Guttmacher Institute, a research and policy nonprofit dedicated to advancing ...

Kennedy casts himself as “anti-establishment,” but he doesn’t object to the cruel profit-driven health care system that ...

The Chicago-based association will also "pick and choose" its advocacy fights regarding topics like vaccines, gender ...

That drew quick pushback from Democratic Sen. Ron Wyden of Oregon — and ensuing back and forth between him and Kennedy. Wyden ...

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...